Mata Nathan L.'s Form 4 filing
Belite Bio, Inc (BLTE) · filed May 1, 2026
- Accession no.
- 0001193125-26-201466
- Filed
- May 1, 2026
- Trade date
- Apr 30, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $157.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mata Nathan L.CIK 0002013987 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | American depositary share | SSaleDisposed | −42 | $155.68F3 | −$6,538.56 | 5,624 | Direct | |
| Apr 30, 2026 | American depositary share | SSaleDisposed | −517 | $156.59F4 | −$80,957.03 | 5,107 | Direct | |
| Apr 30, 2026 | American depositary share | SSaleDisposed | −340 | $157.37F5 | −$53,505.8 | 4,767 | Direct | |
| Apr 30, 2026 | American depositary share | SSaleDisposed | −101 | $158.15F6 | −$15,973.15 | 4,666 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of shares sold at prices that ranged from $155.62 to $155.87. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $156.095 to $156.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of shares sold at prices that ranged from $157 to $157.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of shares sold at prices that ranged from $158.01 to $158.42. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.